Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rho GTPase activating protein 20 pseudogene (ENSG00000250637, LOC100420534) is a genomic sequence with high similarity to the functional ARHGAP20 gene but does not encode a functional protein. Pseudogenes often arise from gene duplication or retrotransposition events and typically contain disruptive mutations (such as frameshifts or premature stop codons) preventing protein translation or function. While the functional ARHGAP20 gene encodes a regulator of Rho-type GTPases involved in cytoskeletal dynamics and cell signaling, the pseudogene does not contribute to these biological processes and has no known functional or pathological role. It is categorized neither as a receptor, enzyme, nor any protein class but is a non-coding DNA segment located in the human genome[6][3]. Important note: - The functional version of the gene, ARHGAP20, is a Rho GTPase-activating protein involved in the regulation of cytoskeletal organization and signaling; it plays roles in conditions like cancer. However, this entry (ENSG00000250637) is a pseudogene—it is not the functional ARHGAP20 gene[1][6][3]. --- To summarize, ENSG00000250637 is not a druggable protein, does not fit protein classification systems (receptor, enzyme, etc.), and should not be confused with the functional ARHGAP20 gene. For research or therapeutic purposes, always use the functional ARHGAP20 (not the pseudogene) if seeking a legitimate Rho GTPase-activating protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho GTPase activating protein 20 pseudogene.